on Mar 31,2026
During the Annual Shareholders Meeting of Feldan Therapeutics, held in March 2026, Chairman of the Board Dr. David J. Mazzo addressed the company’s achievements over the past year and outlined …
Read Storyon Mar 12,2026
Quebec City, QC, March 12, 2026 – Feldan Therapeutics (“Feldan”), a clinical-stage biotech company specializing in the development of therapies based on intracellular delivery, today announced, in partnership with TransBIOTech, …
Read Story
2666, Boul. du Parc Technologique, Suite 290
Quebec, Qc, Canada,
G1P 4S6
Phone: 1-418-872-7277
Email: info@feldan.com